Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Vortioxetine 20 mg Tablets vs Brintellix in healthy Thai participants under fasting
TCTR20260710024Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vortioxetine in major depressive disorder (MDD) (2 arms), sponsored by Bio-innova. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on TCTR20260710024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260710024.